Skip to main content
SpringerLink
Log in

Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin’s lymphoma patients

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Muller-Beissenhirtz H, Kasper C, Nuckel H, Duhrsen U (2005) Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. Ann Hematol 84(12):796–801 Nov

    Article  PubMed  Google Scholar 

  2. Papageorgiou ES, Tsirigotis P, Dimopoulos M, Pavlidis N, Fountzilas G, Papageorgiou S, Economopoulos T (2005) Hellenic Cooperative Oncology Group. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group. Eur J Haematol 75(2):124–129 Aug

    Article  PubMed  CAS  Google Scholar 

  3. Spencer A, Reed K, Arthur C (2007) Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim. Intern Med J 37(11):760–766 Nov

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haematology Division, Sant’Eugenio Hospital, Tor Vergata University, Rome, Italy

    Alessio Pio Perrotti, Pasquale Niscola, Andrea Tendas, Laura Scaramucci, Massimiliano Palombi, Luca Cupelli, Teresa Dentamaro, Daniela Piccioni, Marco Giovannini & Paolo de Fabritis

Authors
  1. Alessio Pio Perrotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pasquale Niscola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Tendas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Scaramucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Massimiliano Palombi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Cupelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Teresa Dentamaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Daniela Piccioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marco Giovannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Paolo de Fabritis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pasquale Niscola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrotti, A.P., Niscola, P., Tendas, A. et al. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin’s lymphoma patients. Ann Hematol 87, 493–494 (2008). https://doi.org/10.1007/s00277-007-0423-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0423-2

Keywords

Search

Navigation